These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 32719810)

  • 1. Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19.
    Zhang B; Zhou X; Zhu C; Song Y; Feng F; Qiu Y; Feng J; Jia Q; Song Q; Zhu B; Wang J
    Front Mol Biosci; 2020; 7():157. PubMed ID: 32719810
    [No Abstract]   [Full Text] [Related]  

  • 2. A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators.
    Tang F; Zhang X; Zhang B; Zhu B; Wang J
    J Med Virol; 2022 Jan; 94(1):131-140. PubMed ID: 34403145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Immune, Inflammatory and Hematological Response in COVID-19 Patients, According to the Severity of the Disease.
    Trofin F; Nastase EV; Vâță A; Iancu LS; Luncă C; Buzilă ER; Vlad MA; Dorneanu OS
    Microorganisms; 2023 Jan; 11(2):. PubMed ID: 36838284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum IgM and IgG levels in COVID-19 patients in Hubei Province, China.
    Bai Z; Li Q; Chen Q; Niu C; Wei Y; Huang H; Zhao W; Chen N; Yao X; Zhang Q; Mu C; Feng J; Zhu C; Li Z; Ding M; Feng B; Jin C; Lu X; Yang Y; Wu S; Shu X; Hu L; Qiu H; Huang Y
    J Intensive Med; 2022 Jan; 2(1):32-38. PubMed ID: 36785701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6, procalcitonin and neutrophil-to-lymphocyte ratio: Potential immune-inflammatory parameters to identify severe and fatal forms of COVID-19.
    Sayah W; Berkane I; Guermache I; Sabri M; Lakhal FZ; Yasmine Rahali S; Djidjeli A; Lamara Mahammed L; Merah F; Belaid B; Berkani L; Lazli NZ; Kheddouci L; Kadi A; Ouali M; Khellafi R; Mekideche D; Kheliouen A; Hamidi RM; Ayoub S; Raaf NB; Derrar F; Gharnaout M; Allam I; Djidjik R
    Cytokine; 2021 May; 141():155428. PubMed ID: 33550165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 patients display changes in lymphocyte subsets with a higher frequency of dysfunctional CD8lo T cells associated with disease severity.
    Onofrio LI; Marin C; Dutto J; Brugo MB; Baigorri RE; Bossio SN; Quiróz JN; Almada L; Ruiz Moreno F; Olivera C; Silvera-Ruiz SM; Ponce NE; Icely PA; Amezcua Vesely MC; Fozzatti L; Rodríguez-Galán MC; Stempin CC; Cervi L; ; Maletto BA; Acosta Rodríguez EV; Bertone M; Abiega CD; Escudero D; Kahn A; Caeiro JP; Maccioni M; Motrán CC; Gruppi A; Sotomayor CE; Chiapello LS; Montes CL
    Front Immunol; 2023; 14():1223730. PubMed ID: 37809093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Value of neutrophil-to-lymphocyte ratio in the classification diagnosis of coronavirus disease 2019].
    Fei M; Tong F; Tao X; Wang J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 May; 32(5):554-558. PubMed ID: 32576346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-SARS-CoV IgG response in relation to disease severity of severe acute respiratory syndrome.
    Lee N; Chan PK; Ip M; Wong E; Ho J; Ho C; Cockram CS; Hui DS
    J Clin Virol; 2006 Feb; 35(2):179-84. PubMed ID: 16112612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutrophil-to-Lymphocyte Ratio as a Predictor of Disease Severity and Mortality in Coronavirus Disease 2019: Prospective Study From Central India.
    Rathod BD; Amle D; Khot RS; Prathipati KK; Joshi PP
    Cureus; 2022 Mar; 14(3):e23696. PubMed ID: 35519791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and roles of severe acute respiratory syndrome coronavirus 2-specific antibodies in patients with different severities of coronavirus 19.
    Huang Z; Chen H; Xue M; Huang H; Zheng P; Luo W; Liang X; Sun B; Zhong N
    Clin Exp Immunol; 2020 Nov; 202(2):210-219. PubMed ID: 32706417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune cell profiling and antibody responses in patients with COVID-19.
    Rezaei M; Mahmoudi S; Mortaz E; Marjani M
    BMC Infect Dis; 2021 Jul; 21(1):646. PubMed ID: 34225645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete Blood-count-based Inflammatory Score (CBCS) of COVID-19 Patients at Tertiary Care Center.
    Kumar Gothwal S; Singh VB; Shrivastava M; Banseria R; Goyal K; Singh S; Ali H; Saad Alharbi K; Singh Y; Gupta G
    Altern Ther Health Med; 2021 Jun; 27(S1):18-24. PubMed ID: 33609349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19.
    Esa T; Budu B; Mulyono B; Soraya GV; Usman AN; Intansari US
    F1000Res; 2023; 12():1189. PubMed ID: 38099004
    [No Abstract]   [Full Text] [Related]  

  • 16. Longitudinal Observation of Immune Response for 23 Months in COVID-19 Convalescent Patients After Infection and Vaccination.
    Xu J; Zheng J; Tan Y; Cai J; Xiang Y; Ling H; Li Z; Bai Q
    Viral Immunol; 2023; 36(6):389-400. PubMed ID: 37276049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection.
    Lin S; Mao W; Zou Q; Lu S; Zheng S
    J Clin Lab Anal; 2021 Jan; 35(1):e23604. PubMed ID: 33184946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-Inflammatory Parameters in COVID-19 Cases: A Systematic Review and Meta-Analysis.
    Feng X; Li S; Sun Q; Zhu J; Chen B; Xiong M; Cao G
    Front Med (Lausanne); 2020; 7():301. PubMed ID: 32582743
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection of IgM and IgG antibodies in patients with coronavirus disease 2019.
    Hou H; Wang T; Zhang B; Luo Y; Mao L; Wang F; Wu S; Sun Z
    Clin Transl Immunology; 2020 May; 9(5):e01136. PubMed ID: 32382418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How immune breakthroughs could slow disease progression and improve prognosis in COVID-19 patients: a retrospective study.
    Wang Y; Zhao B; Zhang X; Zhang X; Gao F; Yuan X; Ren X; Li M; Liu D
    Front Immunol; 2023; 14():1246751. PubMed ID: 37936709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.